Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of CAD 214.70 billion. The enterprise value is 305.29 billion.

Market Cap	214.70B
Enterprise Value	305.29B

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.42%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.66B

Valuation Ratios

The trailing PE ratio is 37.42.

PE Ratio	37.42
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.67, with an EV/FCF ratio of 27.50.

EV / Earnings	53.21
EV / Sales	3.58
EV / EBITDA	10.67
EV / EBIT	18.08
EV / FCF	27.50

Financial Position

The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.73.

Current Ratio	1.00
Quick Ratio	0.64
Debt / Equity	0.73
Debt / EBITDA	3.46
Debt / FCF	8.26
Interest Coverage	3.78

Financial Efficiency

Return on equity (ROE) is 4.54% and return on invested capital (ROIC) is 4.46%.

Return on Equity (ROE)	4.54%
Return on Assets (ROA)	3.31%
Return on Capital (ROIC)	4.46%
Revenue Per Employee	910,462
Profits Per Employee	65,201
Employee Count	88,000
Asset Turnover	0.27
Inventory Turnover	1.64

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.98% in the last 52 weeks. The beta is 0.62, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-7.98%
50-Day Moving Average	12.48
200-Day Moving Average	13.06
Relative Strength Index (RSI)	52.79
Average Volume (20 Days)	88,632

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.15

Income Statement

In the last 12 months, Pfizer had revenue of CAD 80.12 billion and earned 5.74 billion in profits. Earnings per share was 1.00.

Revenue	80.12B
Gross Profit	55.91B
Operating Income	15.51B
Pretax Income	5.27B
Net Income	5.74B
EBITDA	24.78B
EBIT	15.51B
Earnings Per Share (EPS)	1.00

Full Income Statement

Balance Sheet

The company has 13.43 billion in cash and 91.68 billion in debt, giving a net cash position of -78.25 billion.

Cash & Cash Equivalents	13.43B
Total Debt	91.68B
Net Cash	-78.25B
Net Cash Per Share	n/a
Equity (Book Value)	124.90B
Book Value Per Share	21.98
Working Capital	16.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 15.20 billion and capital expenditures -4.10 billion, giving a free cash flow of 11.10 billion.

Operating Cash Flow	15.20B
Capital Expenditures	-4.10B
Free Cash Flow	11.10B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 69.78%, with operating and profit margins of 19.36% and 7.16%.

Gross Margin	69.78%
Operating Margin	19.36%
Pretax Margin	6.58%
Profit Margin	7.16%
EBITDA Margin	30.93%
EBIT Margin	19.36%
FCF Margin	13.86%

Dividends & Yields

Pfizer does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	222.18%
Buyback Yield	0.42%
Shareholder Yield	0.42%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 1.98. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.98
Piotroski F-Score	n/a